Richard Zhu, MD
Pain Medicine · Hartford, CTNPI 1336582881
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $5,624 of the $7,420 with a category attached, or 75.8%. 15 manufacturers reported payments, led by Boston Scientific at 37.7% of the total. Reporting peaked in 2019 at $1,771 and has fallen 58.0% since, to $744 in 2025.
Across 161 payments — averaging $46.09 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boston Scientific$3K
- Medtronic$2K
- SPR Therapeutics, Inc$504
- Bioventus LLC$469
- Nevro Corp.$382
- Si-bone, Inc.$281
- plus $814 from 9 others
What the payments were for
- Consulting fees$3805%
- Travel & lodging$1,31618%
- Food & beverage$5,62476%
- Education$1001%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boston Scientific | 77 | $2,795 |
| Medtronic(2 entities) | 21 | $2,176 |
| SPR Therapeutics, Inc | 26 | $504 |
| Bioventus LLC | 3 | $469 |
| Nevro Corp. | 8 | $382 |
| Si-bone, Inc. | 3 | $281 |
| Johnson & Johnson | 3 | $153 |
| Janssen Scientific Affairs, LLC | 1 | $146 |
| Merck | 8 | $130 |
| GRT US Holding, Inc. | 1 | $115 |
| Abbott | 5 | $100 |
| Saluda Medical Americas, Inc. | 1 | $79 |
| AbbVie(2 entities) | 2 | $44 |
| Haemonetics Corporation | 1 | $24 |
| Cerus Corporation | 1 | $24 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- ADAPTIVESTIM$970
- GENERAL PAIN MANAGEMENT$807
- SPECTRA WAVEWRITER$553
- Stimrouter Implantable Kit$347
- INTELLIS ADAPTIVESTIM$243
- INTELLIS$156
- VANTA ADAPTIVESTIM$151
- iFuse Implant$146
- Tremfya$146
- SPRINT PNS System$125
- Qutenza$115
How this compares
$7,420 in reported general payments places this provider in the 80th percentile of 69 pain medicine providers in Connecticut.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Gabapentin | 39 | $293 |
| Tizanidine Hcl | 42 | $257 |
| Duloxetine Hcl | 12 | $75 |
| Pregabalin | 14 | $72 |
Paid to pharmacies, not to this prescriber.
Other pain medicine in Hartford
- Daniel ChangHartford$2K
- Kamal AjamHartford$759
- Pietro MemmoHartford$168
- Sandeep JoharWaterbury$329K
- David GutierrezNew Haven$151K
- Brian GrosbergWest Hartford$99K
- Ofer WellischStamford$18K
- Yili HuangNew Haven$18K
- Jared RosenbergGreenwich$12K
- Sandhya MehlaWest Hartford$12K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.